Cefoperazone – Injection products
Exceptions to the recognized standard of CLSI M100
| Minimum Inhibitory Concentrations (mcg/mL) | Disk Diffusion (zone diameter in mm) | |||||
|---|---|---|---|---|---|---|
| Pathogen | S | I | R | S | I | R |
| Enterobacteriaceae | ≤ 8 | - | ≥ 16 | - | - | - |
| Other non-Entobacteriaceae | ≤ 8 | - | ≥ 16 | - | - | - |
| Anaerobes | ≤ 8 | - | ≥ 16 | - | - | - |
S = Susceptible; I = Intermediate; R = Resistant
Susceptibility interpretive criteria are based on a dose of 3 g every 6 hours or 4 g every 8 hours in patients with normal renal function.